Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
63
GPCR Quote, Financials, Valuation and Earnings
Last price:
$69.61
Seasonality move
:
-34.19%
Day range:
$63.21 - $71.75
52-week range:
$13.22 - $94.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.33x
Volume:
2.1M
Avg. volume:
2.2M
1-year change:
149.44%
Market cap:
$4.1B
Revenue:
--
EPS (TTM):
-$3.65
Earnings Data
Next earnings date for GPCR
Feb 26
2026
Most recent earnings per share
-$1.13
Missed by $0.70
(Nov 6/2025)
Consensus Estimate
-$0.43
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
GPCR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | -- | -- | -- | -$0.38 | -- |
| 11/06/2025 | Q3 | -- | -- | -$1.13 | -$0.43 | -$0.70 |
| 08/08/2025 | Q2 | -- | -- | -$1.08 | -$0.36 | -$0.71 |
| 05/08/2025 | Q1 | -- | -- | -$0.82 | -$0.23 | -$0.59 |
| 02/27/2025 | Q4 | -- | -- | -$0.63 | -$0.17 | -$0.47 |
| 11/13/2024 | Q3 | -- | -- | -$0.60 | -$0.19 | -$0.41 |
| 08/08/2024 | Q2 | -- | -- | -$0.53 | -$0.23 | -$0.30 |
| 05/09/2024 | Q1 | -- | -- | -$0.56 | -$0.22 | -$0.34 |
| 03/08/2024 | Q4 | -- | -- | -$0.53 | -$0.21 | -$0.32 |
| 11/17/2023 | Q3 | -- | -- | -$0.62 | -- | -- |
| 08/10/2023 | Q2 | -- | -- | -$0.60 | -- | -- |
| 05/11/2023 | Q1 | -- | -- | -$0.75 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.32 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.49 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.42 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.36 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.42 | -- | -- |
Structure Therapeutics, Inc. Earnings Questions
-
How Much did Structure Therapeutics, Inc. Generate in Revenue Last Quarter?
Structure Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Structure Therapeutics, Inc. Beat Earnings Last Quarter?
Structure Therapeutics, Inc. announced earnings per share of -$1.13 which represents a miss of analyst forecast a -$0.43 per share.
-
Is Structure Therapeutics, Inc. Profitable?
Structure Therapeutics, Inc. reported -$978.3K that represents -$0.02 per share over the last quarter.
-
What is the Analyst Consensus for Structure Therapeutics, Inc. EPS Next Year?
Structure Therapeutics, Inc.'s earnings are forecast to decrease from -$2.33 per share to -$0.76 per share next year representing a decrease of -46.6%.
-
When is Structure Therapeutics, Inc.'s Earnings Date?
Structure Therapeutics, Inc.'s next earnings date is February 26, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
